Abstract

SummaryBackgroundAs the COVID-19 pandemic continues, national-level surveillance platforms with real-time individual person-level data are required to monitor and predict the epidemiological and clinical profile of COVID-19 and inform public health policy. We aimed to create a national dataset of patient-level data in Scotland to identify temporal trends and COVID-19 risk factors, and to develop a novel statistical prediction model to forecast COVID-19-related deaths and hospitalisations during the second wave.MethodsWe established a surveillance platform to monitor COVID-19 temporal trends using person-level primary care data (including age, sex, socioeconomic status, urban or rural residence, care home residence, and clinical risk factors) linked to data on SARS-CoV-2 RT-PCR tests, hospitalisations, and deaths for all individuals resident in Scotland who were registered with a general practice on Feb 23, 2020. A Cox proportional hazards model was used to estimate the association between clinical risk groups and time to hospitalisation and death. A survival prediction model derived from data from March 1 to June 23, 2020, was created to forecast hospital admissions and deaths from October to December, 2020. We fitted a generalised additive spline model to daily SARS-CoV-2 cases over the previous 10 weeks and used this to create a 28-day forecast of the number of daily cases. The age and risk group pattern of cases in the previous 3 weeks was then used to select a stratified sample of individuals from our cohort who had not previously tested positive, with future cases in each group sampled from a multinomial distribution. We then used their patient characteristics (including age, sex, comorbidities, and socioeconomic status) to predict their probability of hospitalisation or death.FindingsOur cohort included 5 384 819 people, representing 98·6% of the entire estimated population residing in Scotland during 2020. Hospitalisation and death among those testing positive for SARS-CoV-2 between March 1 and June 23, 2020, were associated with several patient characteristics, including male sex (hospitalisation hazard ratio [HR] 1·47, 95% CI 1·38–1·57; death HR 1·62, 1·49–1·76) and various comorbidities, with the highest hospitalisation HR found for transplantation (4·53, 1·87–10·98) and the highest death HR for myoneural disease (2·33, 1·46–3·71). For those testing positive, there were decreasing temporal trends in hospitalisation and death rates. The proportion of positive tests among older age groups (>40 years) and those with at-risk comorbidities increased during October, 2020. On Nov 10, 2020, the projected number of hospitalisations for Dec 8, 2020 (28 days later) was 90 per day (95% prediction interval 55–125) and the projected number of deaths was 21 per day (12–29).InterpretationThe estimated incidence of SARS-CoV-2 infection based on positive tests recorded in this unique data resource has provided forecasts of hospitalisation and death rates for the whole of Scotland. These findings were used by the Scottish Government to inform their response to reduce COVID-19-related morbidity and mortality.FundingMedical Research Council, National Institute for Health Research Health Technology Assessment Programme, UK Research and Innovation Industrial Strategy Challenge Fund, Health Data Research UK, Scottish Government Director General Health and Social Care.

Highlights

  • Following its emergence in Wuhan, China, in December, 2019, SARS-CoV-2 has spread throughout the world.[1]

  • We aimed to develop a national dataset of individual patient-level primary and secondary care, mortality, and virological and serological testing data in Scotland to assess the temporal progression of the COVID-19 pandemic, risk factors for COVID-19-related hospitalisa­ tion and death, and temporal trends in hospitalisations and deaths by age and risk factor groups

  • We identified risk factors for COVID-19-related hospitalisation and death and temporal trends in the proportion of hospitalisations and deaths by age and risk factor groups among those with a positive RT-PCR test for SARS-CoV-2

Read more

Summary

Introduction

Following its emergence in Wuhan, China, in December, 2019, SARS-CoV-2 has spread throughout the world.[1]. A key aspect of the epidemiological response to COVID-19 has been the use of individual patient health-care data—eg, data for those with a positive RT-PCR test for SARS-CoV-2 who have been hospitalised www.thelancet.com/digital-health Vol 3 August 2021 e517. National-level surveillance platforms can help to monitor and predict the epidemiological and clinical profile of the COVID-19 pandemic and inform public health policy. These platforms have the advantage of including a complete unselected population, with disease introductions and community transmission. We searched Google Scholar on Sept 10, 2020, for Englishlanguage articles relating to national-level surveillance platforms for COVID-19, using the terms “SARS-CoV-2,” “COVID-19,” “surveillance platforms,” “unselected population,” and “individual-level data”. In the six studies identified, we found that most available individual-level data could only identify patients from specific institutions, highly selected populations, or with limited country-wide coverage (eg, limited to patients with severe disease or to only one city)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.